Seres Therapeutics (NASDAQ:MCRB) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Seres Therapeutics missed estimated earnings by 17.31%, reporting an EPS of $-0.61 versus an estimate of $-0.52.
Revenue was down $4.22 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.11 which was followed by a 0.34% increase in the share price the next day.
Here's a look at Seres Therapeutics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.44 | -0.46 | -0.37 | -0.31 |
| EPS Actual | -0.55 | 0.72 | -0.53 | -0.39 |
| Revenue Estimate | 12.25M | 7.32M | 5.34M | 6.45M |
| Revenue Actual | 7.22M | 126.72M | 5.26M | 5.72M |
To track all earnings releases for Seres Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
